ForSight VISION5 is focused on developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy.

Company Name

Forsight VISION5

Location

Menlo Park, CA

Investment Stage

Acquired by Allergan for $95M in August 2016